Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
rheumatology
Providers
Op-ed: CMS drug negotiations boost rheumatological care access
Costs often have patients skipping doses or forgoing their treatments, leading to avoidable hospitalizations, disability and other dire consequences.
Amanda Myers, M.D.
,
Rebecca Shepherd, M.D.
Oct 3, 2025 10:28am
PitchBook predicts PE deal pace could pick up in late 2023
Feb 14, 2023 4:35pm
Motto launches virtual platform for chronic inflammatory care
Oct 26, 2022 9:00am